{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:44:30Z","timestamp":1786729470642,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2307601"],"award-info":[{"award-number":["2023YFC2307601"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40121-026-01405-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:08:47Z","timestamp":1783343327000},"page":"2381-2397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies"],"prefix":"10.1007","volume":"15","author":[{"given":"Le","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-5151","authenticated-orcid":false,"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1405_CR1","unstructured":"Influenza (seasonal)[EB\/OL]. [2026\u201303\u201303]. https:\/\/www.who.int\/health-topics\/influenza-seasonal#tab=tab_1."},{"issue":"1","key":"1405_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13244","volume":"18","author":"C He","year":"2014","unstructured":"He C, Norton D, Temte JL, et al. Effect of planned school breaks on student absenteeism due to influenza-like illness in school aged children-Oregon school district, Wisconsin September 2014-June 2019. Influenza Other Respir Viruses. 2014;18(1):e13244. https:\/\/doi.org\/10.1111\/irv.13244.","journal-title":"Influenza Other Respir Viruses"},{"key":"1405_CR3","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.ijid.2023.04.095","volume":"130","author":"YA Malik","year":"2023","unstructured":"Malik YA. Impact of influenza in South-East Asia. Int J Infect Dis. 2023;130:S40\u20131. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.095.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1405_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-17469-8","volume":"24","author":"LR Dauelsberg","year":"2024","unstructured":"Dauelsberg LR, Maskery B, Joo H, et al. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States. BMC Public Health. 2024;24(1):200. https:\/\/doi.org\/10.1186\/s12889-023-17469-8.","journal-title":"BMC Public Health"},{"issue":"6","key":"1405_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286734","volume":"18","author":"J Park","year":"2023","unstructured":"Park J, Joo H, Maskery BA, et al. Productivity costs associated with reactive school closures related to influenza or influenza-like illness in the United States from 2011 to 2019. PLoS ONE. 2023;18(6):e0286734. https:\/\/doi.org\/10.1371\/journal.pone.0286734.","journal-title":"PLoS ONE"},{"issue":"3","key":"1405_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/cid\/ciae597","volume":"81","author":"MW Tenforde","year":"2023","unstructured":"Tenforde MW, Reeves EL, Weber ZA, et al. Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States. Clin Infect Dis. 2023;81(3):667\u201378. https:\/\/doi.org\/10.1093\/cid\/ciae597.","journal-title":"Clin Infect Dis"},{"key":"1405_CR7","unstructured":"Global influenza programme[EB\/OL]. [2026\u201303\u201303]. https:\/\/www.who.int\/teams\/global-influenza-programme\/vaccines."},{"key":"1405_CR8","unstructured":"CDC. Flu vaccination coverage, united states, 2024\u201325 influenza season[EB\/OL]. (2026\u201302\u201309)[2026\u201303\u201304]. https:\/\/www.cdc.gov\/fluvaxview\/coverage-by-season\/2024-2025.html."},{"issue":"11","key":"1405_CR9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3760\/cma.j.cn112150-20220810-00802","volume":"56","author":"HT Zhao","year":"2022","unstructured":"Zhao HT, Peng ZB, Ni ZL, et al. investigation on influenza vaccination policy and vaccination situation during the influenza seasons of 2020\u20132021 and 2021\u20132022 in China][J\/OL. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 2022;56(11):1561\u20134. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20220810-00802.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]"},{"issue":"24","key":"1405_CR10","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.vaccine.2018.04.077","volume":"36","author":"KE Kahn","year":"2018","unstructured":"Kahn KE, Santibanez TA, Zhai Y, et al. Association between provider recommendation and influenza vaccination status among children. Vaccine. 2018;36(24):3486\u201397. https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.077.","journal-title":"Vaccine"},{"issue":"3","key":"1405_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/vaccines12030233","volume":"12","author":"K Han","year":"2024","unstructured":"Han K, Hou Z, Tu S, et al. Factors influencing childhood influenza vaccination: a systematic review. Vaccines. 2024;12(3):233\u201345. https:\/\/doi.org\/10.3390\/vaccines12030233.","journal-title":"Vaccines"},{"key":"1405_CR12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3852","author":"A K","year":"2020","unstructured":"K A, Aw S, A C, et al. Parental hesitancy about routine childhood and influenza vaccinations: a national survey. Pediatrics. 2020. https:\/\/doi.org\/10.1542\/peds.2019-3852.","journal-title":"Pediatrics"},{"issue":"4","key":"1405_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/vaccines8040590","volume":"8","author":"O Olson","year":"2020","unstructured":"Olson O, Berry C, Kumar N. Addressing parental vaccine hesitancy towards childhood vaccines in the united states: a systematic literature review of communication interventions and strategies. Vaccines (Basel). 2020;8(4):590. https:\/\/doi.org\/10.3390\/vaccines8040590.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"1405_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12879-023-08541-0","volume":"23","author":"RL Carregaro","year":"2023","unstructured":"Carregaro RL, Roscani ANCP, Raimundo ACS, et al. Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews[J\/OL]. BMC Infect Dis. 2023;23(1):563. https:\/\/doi.org\/10.1186\/s12879-023-08541-0.","journal-title":"BMC Infect Dis"},{"key":"1405_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101331","volume":"46","author":"S Minozzi","year":"2022","unstructured":"Minozzi S, Lytras T, Gianola S, et al. Comparative efficacy and safety of vaccines to prevent seasonal influenza: a systematic review and network meta-analysis. EClinicalMedicine. 2022;46:101331. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101331.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"1405_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1080\/21645515.2020.1721994","volume":"16","author":"Y Hu","year":"2020","unstructured":"Hu Y, Shao M, Hu Y, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China. Hum Vaccin Immunother. 2020;16(7):1691\u20138. https:\/\/doi.org\/10.1080\/21645515.2020.1721994.","journal-title":"Hum Vaccin Immunother"},{"key":"1405_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2019.12.010","volume":"92","author":"T Vesikari","year":"2020","unstructured":"Vesikari T, Nauta J, Lapini G, et al. Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: a phase III randomized study. Int J Infect Dis. 2020;92:29\u201337. https:\/\/doi.org\/10.1016\/j.ijid.2019.12.010.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"1405_CR18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s40121-022-00685-x","volume":"11","author":"S Lim","year":"2022","unstructured":"Lim S, Li X, Syrkina O, et al. Post-marketing surveillance of a quadrivalent influenza vaccine (vaxigrip tetra) in South Korea. Infect Dis Ther. 2022;11(5):2035\u201343. https:\/\/doi.org\/10.1007\/s40121-022-00685-x.","journal-title":"Infect Dis Ther"},{"issue":"5","key":"1405_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050467","volume":"13","author":"L Huang","year":"2025","unstructured":"Huang L, Li G, Zhang Y, et al. The safety and immunogenicity of a quadrivalent influenza subunit vaccine in healthy children aged 6\u201335 months: a randomized, blinded and positive-controlled phase III clinical trial. Vaccines. 2025;13(5):467. https:\/\/doi.org\/10.3390\/vaccines13050467.","journal-title":"Vaccines"},{"issue":"29","key":"1405_CR20","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1016\/j.vaccine.2021.05.070","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Y, Wu H, et al. Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: a randomized, double-blind, active-controlled phase 1 clinical trial. Vaccine. 2021;39(29):3871\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.070.","journal-title":"Vaccine"},{"issue":"9","key":"1405_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s40265-024-02083-8","volume":"84","author":"BJ Cowling","year":"2024","unstructured":"Cowling BJ, Okoli GN. Influenza vaccine effectiveness and progress towards a universal influenza vaccine[J\/OL]. Drugs. 2024;84(9):1013\u201323. https:\/\/doi.org\/10.1007\/s40265-024-02083-8.","journal-title":"Drugs"},{"issue":"6","key":"1405_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/v13060971","volume":"13","author":"T Sekiya","year":"2021","unstructured":"Sekiya T, Ohno M, Nomura N, et al. Selecting and using the appropriate influenza vaccine for each individual[J\/OL]. Viruses. 2021;13(6):971. https:\/\/doi.org\/10.3390\/v13060971.","journal-title":"Viruses"},{"issue":"2","key":"1405_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7202a1","volume":"72","author":"LA Grohskopf","year":"2023","unstructured":"Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the advisory committee on immunization practices \u2014 united states, 2023\u201324 influenza season[J\/OL]. MMWR Recomm and Rep. 2023;72(2):1\u201325. https:\/\/doi.org\/10.15585\/mmwr.rr7202a1.","journal-title":"MMWR Recomm and Rep"},{"issue":"1","key":"1405_CR24","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1038\/s41467-023-43842-7","volume":"14","author":"RS Thwaites","year":"2023","unstructured":"Thwaites RS, Uruchurtu ASS, Negri VA, et al. Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine[J\/OL]. Nat Commun. 2023;14(1):8053. https:\/\/doi.org\/10.1038\/s41467-023-43842-7.","journal-title":"Nat Commun"},{"issue":"4","key":"1405_CR25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-055432","volume":"149","author":"AG Sokolow","year":"2022","unstructured":"Sokolow AG, Stallings AP, Kercsmar C, et al. Safety of live attenuated influenza vaccine in children with asthma. Pediatrics. 2022;149(4):e2021055432. https:\/\/doi.org\/10.1542\/peds.2021-055432.","journal-title":"Pediatrics"},{"key":"1405_CR26","unstructured":"Influenza vaccines \u2013 frequently asked questions (FAQs) | NCIRS[EB\/OL]. [2026\u201304\u201304]. https:\/\/ncirs.org.au\/influenza\/influenza-vaccines-frequently-asked-questions-faqs."},{"issue":"6","key":"1405_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.vaccine.2019.11.071","volume":"38","author":"C Huang","year":"2020","unstructured":"Huang C, Fu X, Zhou Y, et al. Comparison of the immunogenicity and safety of quadrivalent and tetravalent influenza vaccines in children and adolescents. Vaccine. 2020;38(6):1332\u201344. https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.071.","journal-title":"Vaccine"},{"issue":"35","key":"1405_CR28","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","volume":"34","author":"AM Moa","year":"2016","unstructured":"Moa AM, Chughtai AA, Muscatello DJ, et al. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials. Vaccine. 2016;34(35):4092\u2013102. https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.064.","journal-title":"Vaccine"},{"issue":"12","key":"1405_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/jech-2023-220781","volume":"77","author":"M Kiely","year":"2023","unstructured":"Kiely M, Tadount F, Lo E, et al. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. J Epidemiol Community Health. 2023;77(12):791\u2013801. https:\/\/doi.org\/10.1136\/jech-2023-220781.","journal-title":"J Epidemiol Community Health"},{"key":"1405_CR30","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7031e1","author":"AM Hause","year":"2020","unstructured":"Hause AM. COVID-19 vaccine safety in adolescents aged 12\u201317 years \u2014 United States, December 14, 2020\u2013July 16, 2021. MMWR Morb Mortal Wkly Rep. 2020. https:\/\/doi.org\/10.15585\/mmwr.mm7031e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1405_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ejhf.2716","volume":"25","author":"A Peikert","year":"2023","unstructured":"Peikert A, Claggett BL, Kim K, et al. Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. Eur J Heart Fail. 2023;25(2):299\u2013310. https:\/\/doi.org\/10.1002\/ejhf.2716.","journal-title":"Eur J Heart Fail"},{"key":"1405_CR32","unstructured":"CDC. ACIP recommendations summary[EB\/OL]. (2026\u201303\u201325)[2026\u201304\u201304]. https:\/\/www.cdc.gov\/flu\/hcp\/acip\/index.html."},{"key":"1405_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00957","volume":"8","author":"A Georgountzou","year":"2017","unstructured":"Georgountzou A, Papadopoulos NG. Postnatal innate immune development: from birth to adulthood. Front Immunol. 2017;8:957. https:\/\/doi.org\/10.3389\/fimmu.2017.00957.","journal-title":"Front Immunol"},{"key":"1405_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","volume":"4","author":"C Herv\u00e9","year":"2019","unstructured":"Herv\u00e9 C, Laup\u00e8ze B, Del Giudice G, et al. The how\u2019s and what\u2019s of vaccine reactogenicity. NPJ Vaccines. 2019;4:39. https:\/\/doi.org\/10.1038\/s41541-019-0132-6.","journal-title":"NPJ Vaccines"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01405-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:24:10Z","timestamp":1786728250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01405-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01405-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Le Hu, Yue Liu, Siyue Jia, Mingwei Wei, Pengfei Jin, Feng Wen, Hongxing Pan, Kai Chu, Yanjun Chen, Zijie Zhang, Jingxin Li has nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a secondary analysis of de-identified data from completed clinical studies and did not involve any new participant recruitment or intervention. The Scientific Research Committee and the Ethics Review Committee of the Jiangsu CDC approved a waiver of additional ethical review for this secondary analysis. The original studies had been approved by the relevant ethics committees, and written informed consent had been obtained from the parents or legal guardians of all participants.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}